Henry Schein, Inc.

Henry Schein, Inc. , formerly known as Schein Henry, is a prominent healthcare solutions provider based in the US, specializing in the distribution of dental and medical products to enhance operational efficiency in healthcare practices. Founded in 1932 in Melville, US, Henry Schein, Inc. operates as a leading supplier of dental and medical products.

The company has adapted its business operations over the years to meet the evolving needs of healthcare providers, with a global presence across North America, Europe, Asia, and Latin America. In January 2025, KKR invested USD 250 million in Henry Schein, Inc. , as part of a PIPE deal. The transaction was later completed in May 2025.

Following the deal, KKR reinvested in the company and now holds a 12% minority stake in its outstanding shares. The company stock ticker symbol is Nasdaq: HSIC. Henry Schein is a leading supplier of dental and medical products, providing a comprehensive range of solutions designed to enhance the operational efficiency of healthcare practices. The company's core offerings include dental supplies, medical supplies, practice management software, and technology solutions tailored for healthcare providers.

These products are utilized by dental and medical professionals to improve patient care, streamline workflows, and ensure compliance with industry standards. Henry Schein serves a diverse client base comprising over 1 million customers globally, including dental and medical practitioners, hospitals, and clinics. Their products are distributed in numerous international markets, including North America, Europe, Asia, and Latin America, addressing the needs of healthcare providers across various regions.